Skip to main content
. 2017 Sep 15;8(46):80971–80980. doi: 10.18632/oncotarget.20901

Table 1. Demographic characteristics and comorbidities of patients with and without polycystic kidney disease (propensity score-matched cohort).

Polycystic kidney disease
Yes(N=6031) No(N=23976)
n % n % p-value
Age, year 0.99
 20-49 2063 34.2 8199 34.2
 50-64 1689 28.0 6718 28.0
 ≥ 65 2279 37.8 9059 37.8
 Mean (SD)# 58.2 17.0 57.9 17.0 0.19
Gender 0.98
 Female 2633 43.7 10471 43.7
 Male 3398 56.3 13505 56.3
Comorbidity
 CKD 1953 32.4 7688 32.1 0.64
 ESRD 1862 30.9 7336 30.6 0.68
 GB stone disease 438 7.26 1681 7.01 0.50
 Hyperlipidemia 591 9.80 2295 9.57 0.59
 Obesity 11 0.18 27 0.11 0.17
 Diabetes 1110 18.4 4382 18.3 0.82
 Alcoholism 66 1.09 233 0.97 0.39
 Chronic HBV infection 213 3.53 790 3.29 0.36
 Chronic HCV infection 202 3.35 754 3.14 0.99
 NAFLD 170 2.82 643 2.68 0.56

Chi-square test; #: T-test.

HBV: Hepatitis B virus; HCV: Hepatitis C virus; NAFLD: Nonalcoholic fatty liver disease.